STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Clinical trials for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo therapy for rare pancreatic cancer enters human trials
Disease control Recruiting nowThis early-phase trial tests whether combining two targeted drugs—sunitinib malate and lutetium Lu 177 dotatate (Lutathera)—is safe and effective for people with advanced pancreatic neuroendocrine tumors. The study enrolls 24 adults whose tumors have spread or cannot be removed. …
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:10 UTC
-
Chemo combo may keep pancreatic cancer at bay after surgery
Disease control Recruiting nowThis study tests whether giving two chemotherapy drugs (capecitabine and temozolomide) after surgery can stop or delay high-risk pancreatic neuroendocrine tumors from coming back. About 141 participants will be randomly assigned to receive the drugs or just be watched. The goal i…
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 10:09 UTC